US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 3.350
  • 0.0000.00%
Close Jan 17 16:00 ET
  • 3.300
  • -0.050-1.49%
Post 19:57 ET
2.33MMarket Cap-0.12P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Transcode Therapeutics (RNAZ.US)$
    TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial
    Tuesday, 14th January at 8:00 am
    Follows Safety Review Committee (SRC) approval based on safety data from patients in Cohorts 1 and 2
    • No significant safety or dose limiting toxicities reported in Cohorts 1 and 2
    • PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results
    BOSTON, Jan. 14, 2025 /PRNewswire/ -- TransCod...
    NOTE!
    1. NFA (Not Financial Advice!)
    2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
    3. Scale out and secure profits.
    4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
    5. I DO NOT give buy or sell advice
    6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
    7. NEVER be a blind follower.
    LASTLY, If you d...
    20
    11
    NOTE!
    1. NFA (Not Financial Advice!)
    2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
    3. Scale out and secure profits.
    4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
    5. I DO NOT give buy or sell advice
    6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
    7. Remember, some stocks may get pumped WITHOUT any catalyst
    8. NEVER be a blind follower.
    LASTLY, If y...
    34
    12
    $Transcode Therapeutics (RNAZ.US)$
    Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
    Tuesday, 7th January at 8:00 am
    TransCode shares to remain listed on Nasdaq
    BOSTON, Jan. 7, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from the NASDAQ Stock Market LLC (Nasdaq) that the Company ...
    $Transcode Therapeutics (RNAZ.US)$ TransCode Therapeutics Regains Nasdaq Compliance For Minimum Bid Price, Shareholders' Equity, And Shareholder Approval Rule
    Benzinga· 1 min ago
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.